This bill seeks to fundamentally alter the legal landscape surrounding medication abortion in the United States through two primary mechanisms. First, it retroactively withdraws the Food and Drug Administration's approval of mifepristone for pregnancy termination, effectively removing this medication from legal use for abortion purposes despite its decades-long approval history. Second, it creates a novel federal cause of action that would allow women to sue for harm allegedly caused by chemical abortion drugs. The legislation represents a significant federal intervention into reproductive healthcare, pharmaceutical regulation, and tort law, aiming to restrict access to medication abortion through both regulatory withdrawal and expanded civil liability. The bill's scope extends beyond mifepristone to encompass other chemical abortion drugs, though the precise definition of this category remains unclear in the provided text.

Who sponsored HR7902?

Diana Harshbarger, John Rose, Neal Dunn, Mark Alford, Sheri Biggs, Tracey Mann, Christopher Smith, Mary Miller, Greg Steube, Ralph Norman, Roger Williams, Andrew Clyde

What is the status of HR7902?

Introduced as of March 12, 2026.

This bill seeks to fundamentally alter the legal landscape surrounding medication abortion in the United States through two primary mechanisms. First, it retroactively withdraws the Food and Drug Administration's approval of mifepristone for pregnancy termination, effectively removing this medication from legal use for abortion purposes despite its decades-long approval history. Second, it creates a novel federal cause of action that would allow women to sue for harm allegedly caused by chemical abortion drugs. The legislation represents a significant federal intervention into reproductive healthcare, pharmaceutical regulation, and tort law, aiming to restrict access to medication abortion through both regulatory withdrawal and expanded civil liability. The bill's scope extends beyond mifepristone to encompass other chemical abortion drugs, though the precise definition of this category remains unclear in the provided text.

Who sponsored HR7902?

Diana Harshbarger, John Rose, Neal Dunn, Mark Alford, Sheri Biggs, Tracey Mann, Christopher Smith, Mary Miller, Greg Steube, Ralph Norman, Roger Williams, Andrew Clyde

What is the status of HR7902?

Introduced as of March 12, 2026.

HR7902 U.S. House: Safeguarding Women from Chemical…

Introduced

H. R. 7902

Introduced in House · April 22, 2026

March 12, 2026

Mrs. Harshbarger introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Safeguarding Women from Chemical Abortion Act”.

Introduced

H. R. 7902

Introduced in House · April 22, 2026

March 12, 2026

A BILL

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Safeguarding Women from Chemical Abortion Act”.

Introduced

H. R. 7902

Introduced in House · April 22, 2026

March 12, 2026

A BILL

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Safeguarding Women from Chemical Abortion Act”.

Introduced

H. R. 7902

Introduced in House · April 22, 2026

March 12, 2026

A BILL

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Safeguarding Women from Chemical Abortion Act”.

H.R.7902

H. R. 7902

H.R.7902

H. R. 7902

H.R.7902

H. R. 7902

H.R.7902

H. R. 7902